BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nemeth ZH, Bogdanovski DA, Barratt-Stopper P, Paglinco SR, Antonioli L, Rolandelli RH. Crohn's Disease and Ulcerative Colitis Show Unique Cytokine Profiles. Cureus. 2017;9:e1177. [PMID: 28533995 DOI: 10.7759/cureus.1177] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Lu J, Liu D, Tan Y, Deng F, Li R. M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation. J Cell Mol Med 2021;25:3041-50. [PMID: 33569850 DOI: 10.1111/jcmm.16348] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019;25:4796-804. [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
3 Singh SP, Chand HS, Banerjee S, Agarwal H, Raizada V, Roy S, Sopori M. Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis. Dig Dis Sci 2020;65:141-9. [PMID: 31643033 DOI: 10.1007/s10620-019-05838-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Rattigan R, O'Doherty JV, Vigors S, Ryan MT, Sebastiano RS, Callanan JJ, Thornton K, Rajauria G, Margassery LM, Dobson ADW, O'Leary ND, Sweeney T. The Effects of the Marine-Derived Polysaccharides Laminarin and Chitosan on Aspects of Colonic Health in Pigs Challenged with Dextran Sodium Sulphate. Mar Drugs 2020;18:E262. [PMID: 32429425 DOI: 10.3390/md18050262] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
5 Hodzic Z, Schill EM, Bolock AM, Good M. IL-33 and the intestine: The good, the bad, and the inflammatory. Cytokine. 2017;100:1-10. [PMID: 28687373 DOI: 10.1016/j.cyto.2017.06.017] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 8.6] [Reference Citation Analysis]
6 Mansour NM, Elkalla WS, Ragab YM, Ramadan MA. Inhibition of acetic acid-induced colitis in rats by new Pediococcus acidilactici strains, vitamin producers recovered from human gut microbiota. PLoS One 2021;16:e0255092. [PMID: 34310635 DOI: 10.1371/journal.pone.0255092] [Reference Citation Analysis]
7 Shastri S, Shinde T, Woolley KL, Smith JA, Gueven N, Eri R. Short-Chain Naphthoquinone Protects Against Both Acute and Spontaneous Chronic Murine Colitis by Alleviating Inflammatory Responses. Front Pharmacol 2021;12:709973. [PMID: 34497514 DOI: 10.3389/fphar.2021.709973] [Reference Citation Analysis]
8 Dudek P, Fabisiak A, Zatorski H, Malecka-Wojciesko E, Talar-Wojnarowska R. Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment. J Clin Med 2021;10:5660. [PMID: 34884361 DOI: 10.3390/jcm10235660] [Reference Citation Analysis]
9 Mohamed MF, Klünder B, Lacerda AP, Othman AA. Exposure-Response Analyses for Upadacitinib Efficacy and Safety in the Crohn's Disease CELEST Study and Bridging to the Extended-Release Formulation. Clin Pharmacol Ther 2020;107:639-49. [PMID: 31594037 DOI: 10.1002/cpt.1668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kathrani A, Lezcano V, Hall EJ, Jergens AE, Seo YJ, Mochel JP, Atherly T, Allenspach K. Interleukin-13 and interleukin-33 mRNA are underexpressed in the duodenal mucosa of German Shepherd dogs with chronic enteropathy. J Vet Intern Med 2019;33:1660-8. [PMID: 31169944 DOI: 10.1111/jvim.15544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Cleenewerk L, Garssen J, Hogenkamp A. Clinical Use of Schistosoma mansoni Antigens as Novel Immunotherapies for Autoimmune Disorders. Front Immunol 2020;11:1821. [PMID: 32903582 DOI: 10.3389/fimmu.2020.01821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Weiß F, Czichos C, Knobe L, Voges L, Bojarski C, Michel G, Fromm M, Krug SM. MarvelD3 Is Upregulated in Ulcerative Colitis and Has Attenuating Effects during Colitis Indirectly Stabilizing the Intestinal Barrier. Cells 2022;11:1541. [DOI: 10.3390/cells11091541] [Reference Citation Analysis]
13 Wood PL, Steinman M, Erol E, Carter C, Christmann U, Verma A. Lipidomic analysis of immune activation in equine leptospirosis and Leptospira-vaccinated horses. PLoS One 2018;13:e0193424. [PMID: 29474474 DOI: 10.1371/journal.pone.0193424] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
14 Mohammad Rahimi H, Yadegar A, Asadzadeh Aghdaei H, Mirjalali H, Zali MR. Modulation of microRNAs and claudin-7 in Caco-2 cell line treated with Blastocystis sp., subtype 3 soluble total antigen. BMC Microbiol 2022;22:111. [PMID: 35459091 DOI: 10.1186/s12866-022-02528-8] [Reference Citation Analysis]
15 Longo S, Chieppa M, Cossa LG, Spinelli CC, Greco M, Maffia M, Giudetti AM. New Insights into Inflammatory Bowel Diseases from Proteomic and Lipidomic Studies. Proteomes 2020;8:18. [PMID: 32784952 DOI: 10.3390/proteomes8030018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Chojnacki C, Błasiak J, Fichna J, Chojnacki J, Popławski T. Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis. Molecules 2018;23:E272. [PMID: 29382152 DOI: 10.3390/molecules23020272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
17 Chen Y, Wang Y, Shen J. Role of environmental factors in the pathogenesis of Crohn’s disease: a critical review. Int J Colorectal Dis 2019;34:2023-34. [DOI: 10.1007/s00384-019-03441-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Braga YLL, Neto JRC, Costa AWF, Silva MVT, Silva MV, Celes MRN, Oliveira MAP, Joosten LAB, Ribeiro-dias F, Gomes RS, Machado JR, Aga SS. Interleukin-32γ in the Control of Acute Experimental Chagas Disease. Journal of Immunology Research 2022;2022:1-9. [DOI: 10.1155/2022/7070301] [Reference Citation Analysis]
19 Liu H, Dasgupta S, Fu Y, Bailey B, Roy C, Lightcap E, Faustin B. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD. BMC Immunol. 2019;20:42. [PMID: 31718550 DOI: 10.1186/s12865-019-0322-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
20 Saez A, Gomez-Bris R, Herrero-Fernandez B, Mingorance C, Rius C, Gonzalez-Granado JM. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease. Int J Mol Sci 2021;22:7618. [PMID: 34299236 DOI: 10.3390/ijms22147618] [Reference Citation Analysis]
21 Candelli M, Franza L, Pignataro G, Ojetti V, Covino M, Piccioni A, Gasbarrini A, Franceschi F. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2021;22:6242. [PMID: 34200555 DOI: 10.3390/ijms22126242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Weglage J, Wolters F, Hehr L, Lichtenberger J, Wulz C, Hempel F, Baier A, Quack T, Köhler K, Longerich T, Schramm G, Irungbam K, Mueller H, von Buelow V, Tschuschner A, Odenthal M, Drebber U, Arousy ME, Ramalho LNZ, Bankov K, Wild P, Pons-Kühnemann J, Tschammer J, Grevelding CG, Roeb E, Roderfeld M. Schistosoma mansoni eggs induce Wnt/β-catenin signaling and activate the protooncogene c-Jun in human and hamster colon. Sci Rep 2020;10:22373. [PMID: 33361772 DOI: 10.1038/s41598-020-79450-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Sun X, Huang Y, Zhang YL, Qiao D, Dai YC. Research advances of vasoactive intestinal peptide in the pathogenesis of ulcerative colitis by regulating interleukin-10 expression in regulatory B cells. World J Gastroenterol 2020; 26(48): 7593-7602 [PMID: 33505138 DOI: 10.3748/wjg.v26.i48.7593] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Gamez-Belmonte R, Erkert L, Wirtz S, Becker C. The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses. Int J Mol Sci 2020;21:E9772. [PMID: 33371444 DOI: 10.3390/ijms21249772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Stark JM, Tibbitt CA, Coquet JM. The Metabolic Requirements of Th2 Cell Differentiation. Front Immunol 2019;10:2318. [PMID: 31611881 DOI: 10.3389/fimmu.2019.02318] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
26 Velikova TV, Miteva L, Stanilov N, Spassova Z, Stanilova SA. Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer. World J Gastroenterol 2020; 26(16): 1912-1925 [PMID: 32390702 DOI: 10.3748/wjg.v26.i16.1912] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
27 Figliuolo da Paz VR, Jamwal DR, Kiela PR. Intestinal Regulatory T Cells. Adv Exp Med Biol 2021;1278:141-90. [PMID: 33523448 DOI: 10.1007/978-981-15-6407-9_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sun L, Kong R, Li H, Wang D. The Role of T Follicular Helper Cells and Interleukin-21 in the Pathogenesis of Inflammatory Bowel Disease. Gastroenterol Res Pract 2021;2021:9621738. [PMID: 34471409 DOI: 10.1155/2021/9621738] [Reference Citation Analysis]
29 Tindemans I, Joosse ME, Samsom JN. Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD. Cells 2020;9:E110. [PMID: 31906479 DOI: 10.3390/cells9010110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
30 Diab J, Al-Mahdi R, Gouveia-Figueira S, Hansen T, Jensen E, Goll R, Moritz T, Florholmen J, Forsdahl G. A Quantitative Analysis of Colonic Mucosal Oxylipins and Endocannabinoids in Treatment-Naïve and Deep Remission Ulcerative Colitis Patients and the Potential Link With Cytokine Gene Expression. Inflamm Bowel Dis 2019;25:490-7. [PMID: 30476077 DOI: 10.1093/ibd/izy349] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
31 Uchiyama K, Takagi T, Mizushima K, Kajiwara-Kubota M, Kashiwagi S, Toyokawa Y, Tanaka M, Hotta Y, Kamada K, Ishikawa T, Konishi H, Kishimoto M, Naito Y, Itoh Y. Increased mucosal IL-12 expression is associated with relapse of ulcerative colitis. BMC Gastroenterol 2021;21:122. [PMID: 33730998 DOI: 10.1186/s12876-021-01709-5] [Reference Citation Analysis]
32 Zhang L, Zhang J, Su S, Luo S. Changes in interleukin-27 levels in patients with acute coronary syndrome and their clinical significance. PeerJ 2019;7:e5652. [PMID: 30631648 DOI: 10.7717/peerj.5652] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Fu SH, Chien MW, Hsu CY, Liu YW, Sytwu HK. Interplay between Cytokine Circuitry and Transcriptional Regulation Shaping Helper T Cell Pathogenicity and Plasticity in Inflammatory Bowel Disease. Int J Mol Sci 2020;21:E3379. [PMID: 32403220 DOI: 10.3390/ijms21093379] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Ullrich KA, Schulze LL, Paap EM, Müller TM, Neurath MF, Zundler S. Immunology of IL-12: An update on functional activities and implications for disease. EXCLI J 2020;19:1563-89. [PMID: 33408595 DOI: 10.17179/excli2020-3104] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
35 T Virtanen A, Haikarainen T, Raivola J, Silvennoinen O. Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases. BioDrugs 2019;33:15-32. [PMID: 30701418 DOI: 10.1007/s40259-019-00333-w] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 25.3] [Reference Citation Analysis]
36 McEntee CP, Finlay CM, Lavelle EC. Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation. Front Immunol 2019;10:1266. [PMID: 31231388 DOI: 10.3389/fimmu.2019.01266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
37 Imam T, Park S, Kaplan MH, Olson MR. Effector T Helper Cell Subsets in Inflammatory Bowel Diseases. Front Immunol 2018;9:1212. [PMID: 29910812 DOI: 10.3389/fimmu.2018.01212] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 19.0] [Reference Citation Analysis]
38 Charoenngam N, Holick MF. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients 2020;12:E2097. [PMID: 32679784 DOI: 10.3390/nu12072097] [Cited by in Crossref: 79] [Cited by in F6Publishing: 79] [Article Influence: 39.5] [Reference Citation Analysis]
39 Huang Q, Cao W, Mielke LA, Seillet C, Belz GT, Jacquelot N. Innate Lymphoid Cells in Colorectal Cancers: A Double-Edged Sword. Front Immunol 2019;10:3080. [PMID: 32010138 DOI: 10.3389/fimmu.2019.03080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Isidori M, Corbee RJ, Trabalza-marinucci M. Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy—A Narrative Review. Veterinary Sciences 2022;9:37. [DOI: 10.3390/vetsci9020037] [Reference Citation Analysis]
41 Owusu G, Obiri DD, Ainooson GK, Osafo N, Antwi AO, Duduyemi BM, Ansah C. Acetic Acid-Induced Ulcerative Colitis in Sprague Dawley Rats Is Suppressed by Hydroethanolic Extract of Cordia vignei Leaves through Reduced Serum Levels of TNF-α and IL-6. Int J Chronic Dis 2020;2020:8785497. [PMID: 32090060 DOI: 10.1155/2020/8785497] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
42 Gonzalez Acera M, Patankar JV, Diemand L, Siegmund B, Neurath MF, Wirtz S, Becker C. Comparative Transcriptomics of IBD Patients Indicates Induction of Type 2 Immunity Irrespective of the Disease Ideotype. Front Med (Lausanne) 2021;8:664045. [PMID: 34136502 DOI: 10.3389/fmed.2021.664045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Cho SX, Rudloff I, Lao JC, Pang MA, Goldberg R, Bui CB, McLean CA, Stock M, Klassert TE, Slevogt H, Mangan NE, Cheng W, Fischer D, Gfroerer S, Sandhu MK, Ngo D, Bujotzek A, Lariviere L, Schumacher F, Tiefenthaler G, Beker F, Collins C, Kamlin COF, König K, Malhotra A, Tan K, Theda C, Veldman A, Ellisdon AM, Whisstock JC, Berger PJ, Nold-Petry CA, Nold MF. Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities. Nat Commun 2020;11:5794. [PMID: 33188181 DOI: 10.1038/s41467-020-19400-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]